Page last updated: 2024-10-20

phosphorylethanolamine and Leukemia, Myeloid

phosphorylethanolamine has been researched along with Leukemia, Myeloid in 1 studies

phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.

Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fontana, D1
Mauri, M1
Renso, R1
Docci, M1
Crespiatico, I1
Røst, LM1
Jang, M1
Niro, A1
D'Aliberti, D1
Massimino, L1
Bertagna, M1
Zambrotta, G1
Bossi, M1
Citterio, S1
Crescenzi, B1
Fanelli, F1
Cassina, V1
Corti, R1
Salerno, D1
Nardo, L1
Chinello, C1
Mantegazza, F1
Mecucci, C1
Magni, F1
Cavaletti, G1
Bruheim, P1
Rea, D1
Larsen, S1
Gambacorti-Passerini, C1
Piazza, R1

Other Studies

1 other study available for phosphorylethanolamine and Leukemia, Myeloid

ArticleYear
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine.
    Nature communications, 2020, 11-23, Volume: 11, Issue:1

    Topics: Cell Line; Cell Respiration; DNA Breaks; Electron Transport Complex II; Ethanolamines; Humans; Leuke

2020